DocSym
β
Searchsearch
Search
(G36) Other acute disseminated demyelination
More details coming soon
130 042 in individuals diagnosis other acute disseminated demyelination confirmed
3 544 deaths with diagnosis other acute disseminated demyelination
3% mortality rate associated with the disease other acute disseminated demyelination
Diagnosis other acute disseminated demyelination is diagnosed Women are 41.07% more likely than Men
38 319
Men receive the diagnosis other acute disseminated demyelination
2 227 (5.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
91 723
Women receive the diagnosis other acute disseminated demyelination
1 317 (1.4 %)Died from this diagnosis.
Risk Group for the Disease other acute disseminated demyelination - Men aged 40-44 and Women aged 45-49
In Men diagnosis is most often set at age 5-84
Less common in men the disease occurs at Age 0-5, 85-95+Less common in women the disease occurs at Age 0-1, 80-89, 95+
In Women diagnosis is most often set at age 0-79, 90-94
Disease Features other acute disseminated demyelination
Absence or low individual and public risk
Other acute disseminated demyelination - what does this mean
Other acute disseminated demyelination is a rare disorder that affects the central nervous system by causing inflammation and destruction of myelin, the protective sheath that surrounds nerve fibers. this damage disrupts the transmission of nerve signals, resulting in a wide range of neurological symptoms, including vision loss, weakness, numbness, and difficulty with coordination and balance.
What happens during the disease - other acute disseminated demyelination
Other acute disseminated demyelination is a condition in which the protective sheath that covers nerve cells, known as myelin, is damaged. this damage can occur due to an autoimmune reaction, in which the body’s own immune system mistakenly attacks healthy myelin, or due to a viral infection. the damage to the myelin causes a disruption in the transmission of signals between the brain and other parts of the body, leading to a variety of neurological symptoms.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Neurological examination
- MRI scan of the brain
- Cerebrospinal fluid analysis
- Blood tests
- Electroencephalogram (EEG)
- Evoked potential tests
- Visual evoked potentials (VEP)
- Brainstem auditory evoked potentials (BAEP)
Treatment and Medical Assistance
Main Goal: To reduce inflammation, promote remyelination, and improve neurologic function
- Administering corticosteroids to reduce inflammation
- Administering intravenous immunoglobulin to reduce inflammation
- Administering plasmapheresis to reduce inflammation
- Administering immunosuppressant drugs to reduce inflammation
- Providing physical therapy to improve motor function
- Providing occupational therapy to improve daily functioning
- Providing speech therapy to improve communication
- Providing cognitive behavioral therapy to improve mental health
- Administering stem cell therapy to promote remyelination
- Administering growth factor therapy to promote remyelination
- Administering gene therapy to promote remyelination
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other acute disseminated demyelination - Prevention
The best way to prevent other acute disseminated demyelination is to maintain a healthy lifestyle, which includes regular exercise, a balanced diet, and stress management. additionally, it is important to get regular check-ups and to be aware of any symptoms that may indicate an autoimmune disorder. vaccinations and avoiding contact with those who are infected can also help reduce the risk of developing this condition.